Network – Sites & Partners
Advancing Imaging Together
for Patient Care
From Guadeloupe to Orsay and Nancy, AVELION collaborates with imaging centers and research institutions to deploy cyclotrons, microfluidic synthesizer and radiopharmaceutical. These partnerships enable on-site radioisotope production, support clinical and preclinical research, and accelerate access to innovative diagnostics and therapies, strengthening patient care and the development of personalized.
CIMGUA: The first cyclotron in the Carribean Islands
CIMGUA (Molecular Imaging Center of Guadeloupe) is the first molecular imaging center opened in 2028 in the Caribbean equipped with an on-site 12 MeV cyclotron and a PET scanner, enabling local production of radioisotopes and daily PET imaging for patients. Designed, manufactured and installed by AVELION, the cyclotron allows the center to produce short half-life radiotracers such as ¹⁸F-FDG, ¹⁸F-Choline and ¹⁸F-PSMA, ensuring full autonomy for up to 26 patients per day. By providing local access to advanced molecular imaging, CIMGUA has significantly improved equity of access to care for patients in Guadeloupe, eliminating the need for travel to mainland France and strengthening cancer diagnosis, follow-up and future theranostic developments in the region.
CEA-SHFJ : 1st iMiGiNE System commissioned
AVELION and the CEA-SHFJ in Orsay have built a long-standing strategic partnership to deploy the iMiGiNE platform in 2020, the result of nearly ten years of close collaboration supported by Bpifrance.
The CEA is a key player in research, development and innovation in four major areas: energy transition, digital transition, technology for future medicine and defense and security. The CEA conducts fundamental research in the fields of biotechnology and health, physical sciences, earth sciences and astronomy, physics and nanosciences. Its main objectives are the production and publication of knowledge and expertise at the highest international level. In 2019, nearly 3,800 scientific articles were published by CEA researchers, three-quarters of which were the result of international collaboration.
The SHFJ (Frederic-Joliot Hospital Service) is a molecular and functional imaging center installed on the Orsay hospital site. With a medical service one side and a research and development on the other, the objective of this center is to create new imaging tools to improve the diagnosis and evaluation of innovative therapies.
Nancyclotep: A Leading RTIV Platform in France
Founded in 2007, Nancyclotep develops and offers solutions ranging from R&D to clinical studies and production, enabling, to meet the needs for transferring radiopharmaceuticals to the clinical setting.
Nancyclotep features state-of-the-art facilities including a radiochemistry and radiopharmacy laboratory, a preclinical studies platform, an industrial production laboratory, 3 PET-scans, an e-learning laboratory offering innovative solutions and a hospital environment providing immediate access to both medical expertise and patients for technological applications for clinical use.
AVELION and Nancyclotep join forces to meet the challenges of tomorrow’s healthcare and Nuclear Medicine to:
- Promote the research and development of new molecules of clinical interest
- Improve and optimize iMiGiNE’s industrial processes and operations in a hospital environment
- Participate in the transition from conventional to personalized medicine, specifically for companion tests related to targeted treatments
FIGEDIM Project 2020 – Greater East Region
AVELION and Nancyclotep join forces to meet the Challenges of tomorrow’s healthcare:
- Promote the research and development of new molecules of clinical interest
- Improve and optimize iMiGiNE’s industrial processes and operations in a hospital environment
- Participate in the transition from conventional to personalized medicine, particularly for companion tests related to targeted treatments
Map of systems installed
